Back
Lyell Immunopharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
59
LYEL
Lyell Immunopharma
Last Price:
2.74
Seasonality Move:
37.44%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.12
Seasonality Move:
-0.33%
Buy
59
Lyell Immunopharma (LYEL)
is a Buy
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $2.74. The Score for LYEL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.12. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $2.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 60.07 | Buy |
Chaikin Money Flow: | -575819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.26 - 2.58) | Buy |
Bollinger Bands (100): | (1.93 - 2.53) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 66.72 | Buy |
Chaikin Money Flow: | -109706734 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.08 - 0.1) | Buy |
Bollinger Bands (100): | (0.09 - 0.17) | Sell |
LYEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.59 | Buy |
20-day SMA: | 2.44 | Buy |
50-day SMA: | 2.32 | Buy |
200-day SMA: | 2.06 | Buy |
8-day EMA: | 2.61 | Buy |
20-day EMA: | 2.49 | Buy |
50-day EMA: | 2.37 | Buy |
200-day EMA: | 2.36 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.1 | Buy |
20-day SMA: | 0.09 | Buy |
50-day SMA: | 0.1 | Buy |
200-day SMA: | 0.28 | Sell |
8-day EMA: | 0.1 | Buy |
20-day EMA: | 0.09 | Buy |
50-day EMA: | 0.11 | Buy |
200-day EMA: | 0.5 | Sell |
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Lyell Immunopharma Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |